• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bacterial elimination and therapeutic effectiveness under different schedules of amoxicillin administration.

作者信息

Klaus U, Henninger W, Jacobi P, Wiedemann B

出版信息

Chemotherapy. 1981;27(3):200-8. doi: 10.1159/000237978.

DOI:10.1159/000237978
PMID:7014128
Abstract

Bacterial elimination kinetics under different simulated administration schedules of amoxicillin was followed in vitro by using a simple model for simulation of pharmacokinetic parameters. The results were compared to those obtained in lethally infected mice by determining the viable bacterial count in the blood at various times post-infection and under different schedules of amoxicillin administration. A satisfactory correlation could be established between the in vitro and in vivo results. Multiple administration of amoxicillin was found to induce a beta-lactamase in vitro as well as in vivo in the Escherichia coli strain used. No difference was however found between the various administration schedules of amoxicillin in terms of surviving animals. Taking into account the lasting elimination of viable bacteria from the blood, the best treatment of E. coli-infected mice was found to be a twice daily administration of the higher amoxicillin dose.

摘要

相似文献

1
Bacterial elimination and therapeutic effectiveness under different schedules of amoxicillin administration.
Chemotherapy. 1981;27(3):200-8. doi: 10.1159/000237978.
2
Amoxicillin: microbiological activity in vitro and in vivo (author's transl).阿莫西林:体内外微生物学活性(作者译)
Antibiotica. 1973 Sep-Dec;11(3-4):117-33.
3
In vivo activity of amoxicillin.阿莫西林的体内活性。
Adv Clin Pharmacol. 1974;7:40-7.
4
β-Lactamases in amoxicillin-clavulanate-resistant Escherichia coli strains isolated from a Chinese tertiary hospital.β-内酰胺酶在耐阿莫西林克拉维酸的大肠埃希菌中的分布 来自中国一家三甲医院的分离株
Diagn Microbiol Infect Dis. 2013 Aug;76(4):532-3. doi: 10.1016/j.diagmicrobio.2013.04.015. Epub 2013 May 29.
5
[Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].[在阿莫西林与克拉维酸联合治疗期间出现高产头孢菌素酶的大肠杆菌菌株]
Ann Biol Clin (Paris). 1990;48(7):449-54.
6
In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.美西林和阿莫西林/克拉维酸对产TEM-1、Oxa-1和染色体β-内酰胺酶的大肠杆菌菌株的体外活性。
Arzneimittelforschung. 1988 Jul;38(7):863-5.
7
Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.用阿莫西林/克拉维酸治疗产超广谱β-内酰胺酶的耐多药大肠杆菌引起的下尿路感染:病例报告及分离株特征分析
J Antimicrob Chemother. 2006 Jun;57(6):1262-3. doi: 10.1093/jac/dkl102. Epub 2006 Mar 24.
8
[Effectiveness of amoxicillin in infectious endocarditis].
Wiad Lek. 1985 Apr 1;38(7):480-4.
9
Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.阿莫西林-克拉维酸对由耐头孢西丁的非高产AmpC临床分离大肠杆菌引起的小鼠肺炎实验模型的疗效。
Clin Microbiol Infect. 2008 Jun;14(6):582-7. doi: 10.1111/j.1469-0691.2008.01948.x. Epub 2008 Feb 22.
10
Intravenous amoxicillin-sulbactam against Escherichia coli: optimizing the dose, component ratio and infusion time using a human pharmacodynamic model.静脉注射阿莫西林-舒巴坦治疗大肠杆菌:利用人体药效学模型优化剂量、组分比例和输注时间
J Chemother. 2009 Jun;21(3):296-301. doi: 10.1179/joc.2009.21.3.296.

引用本文的文献

1
Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.在体外药代动力学模型中持续和间歇输注头孢他啶期间对铜绿假单胞菌的杀灭作用。
Antimicrob Agents Chemother. 1994 May;38(5):931-6. doi: 10.1128/AAC.38.5.931.
2
Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.在动态体外模型中评估阿洛西林和西索米星浓度降低对铜绿假单胞菌的联合作用。
Infection. 1982;10 Suppl 3:S229-33. doi: 10.1007/BF01640679.
3
Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations.
脉冲给药与抗生素持续输注。药代动力学-药效学考量
Clin Pharmacokinet. 1988 Feb;14(2):71-95. doi: 10.2165/00003088-198814020-00002.
4
In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coli.氨苄西林给药方案对大肠杆菌杀菌活性决定因素的体外评估
Antimicrob Agents Chemother. 1989 Jul;33(7):1046-51. doi: 10.1128/AAC.33.7.1046.